United States · FDA National Drug Code directory
Hydralazine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0517-0901_5aca9ccd-3ac3-48b6-9372-34ee0eb4b7f9
- Product NDC
- 0517-0901
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Hydralazine Hydrochloride
- Labeler
- American Regent, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19970630
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDRALAZINE HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-0901-25) / 1 mL in 1 VIAL, SINGLE-DOSE · 0517-0901-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →